Buy Ipca Laboratories Limited and Divi’s Laboratories Limited

Buy Ipca Laboratories Limited:

Ipca Laboratories Limited

Ipca Laboratories Ltd has officially announced a consolidated sales of Rs. 1,409.83 Cr for the third quarter finished on 31-12-2020, which is 3.58% up from its previous quarter sales of Rs. 1,361.10 Cr and 16.24% up from its previous year same quarter sales of Rs. 1,212.86 Cr. The company has reported a net profit after tax of Rs. 269.77 Cr in the previous quarter.

Outlook:

Ipca Laboratories Ltd: Experts suggested buy call at current market price: Rs. 2,030.1 with a target price: Rs. 2,205.

Buy Divi’s Laboratories Limited:

Divi's Laboratories Limited

Divi’s Laboratories Ltd has officially announced a consolidated sales of Rs. 1,720.76 Cr for the third quarter finished on 31-12-2020, which is -2.39% down from its previous quarter sales of Rs. 1,762.94 Cr and 19.67% up from its previous year same quarter sales of Rs. 1,437.93 Cr. The company has reported a net profit after tax of Rs. 470.62 Cr in the previous quarter.

Outlook:

Divi’s Laboratories Ltd: Experts suggested buy call at current market price: Rs. 3,722.9 with a target price: Rs. 3,773.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

Leave a Reply

Your email address will not be published. Required fields are marked *